Evidence map›Paper›PMID 39744697›Full record

ReviewTheranostics2025

Advancements in GelMA bioactive hydrogels: Strategies for infection control and bone tissue regeneration.

Lei Huang, Ziyao Guo, Xiaoxia Yang, Yinchun Zhang, Yiyun Liang, Xiaxue Chen, Xiaoling Qiu, Xuan Chen

Abstract readReview
In one paragraph

Review in Theranostics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Identification of a Force-Induced Sox9Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  14. Review
  15. Review
  16. Tri-Functional MgTA@MnOInternational journal of nanomedicine · 2026
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lei HuangDepartment of Endodontics, Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, China.
Ziyao GuoSCP 11A of the International Department, Guangzhou Experimental Foreign Language School, Guangzhou, China.
Xiaoxia YangDepartment of Endodontics, Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, China.
Yinchun ZhangDepartment of Periodontology, Shaoxing Stomatological Hospital, Shaoxing, Zhejiang, China.
Yiyun LiangDepartment of Endodontics, Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, China.
Xiaxue ChenDepartment of Endodontics, Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, China.
Xiaoling QiuDepartment of Endodontics, Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, China.
Xuan ChenDepartment of Endodontics, Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infectious bone defects present a significant clinical challenge, characterized by infection, inflammation, and subsequent bone tissue destruction. Traditional treatments, including antibiotic therapy, surgical debridement, and bone grafting, often fail to address these defects effectively. However, recent advancements in biomaterials research have introduced innovative solutions for managing infectious bone defects. GelMA, a three-dimensional network of hydrophilic polymers that can absorb and retain substantial amounts of water, has attracted considerable attention in the fields of materials science and biomedical engineering. Its distinctive properties, such as biocompatibility, responsiveness to stimuli, and customisable mechanical characteristics make GelMA an exemplary scaffold material for bone tissue engineering. This review aims to thoroughly explore the current literature on antibacterial and osteogenic strategies using GelMA hydrogels for the restoration of infected bones. It discusses their fabrication methods, biocompatibility, antibacterial effectiveness, and bioactivity. We conclude by discussing the existing challenges and future research directions in this field, with the hope of inspiring further innovations in the synthesis, modification, and application of GelMA-based hydrogels for infection control and bone tissue regeneration.

Indexed as

Anti-Bacterial AgentsBiocompatible MaterialsBone RegenerationHydrogelsTissue EngineeringTissue ScaffoldsAnimalsBone and BonesHumansInfection ControlOsteogenesisAnti-Bacterial AgentsBiocompatible MaterialsHydrogelsantimicrobial materialsbone tissue regenerationGelMA hydrogelsinfected bone tissue regenerationinfection control

Identifiers

PMID39744697
PMCPMC11671377

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.